Clofazimine serum concentration and safety/efficacy in nontuberculous mycobacterial pulmonary disease treatment.
Fumiya WatanabeKeiji FujiwaraKoji FuruuchiMasashi ItoKazuhiko HanadaTatsuya KodamaAkio AonoSatoshi MitaraiTakashi YoshiyamaAtsuyuki KurashimaKen OhtaKozo MorimotoPublished in: Respiratory medicine (2024)
CFZ-induced pigmentation and QT interval prolongation are associated with serum CFZ concentrations. CFZ dosage may be optimized by monitoring serum CFZ concentration.